BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26379274)

  • 1. Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
    Nagayama K; Kyotani Y; Zhao J; Ito S; Ozawa K; Bolstad FA; Yoshizumi M
    PLoS One; 2015; 10(9):e0137960. PubMed ID: 26379274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 attenuates Ang II-induced proliferation and migration in rat aorta smooth muscle cells
    Xiong QF; Fan SH; Zhang X; Niu Y; Li XW; Shi YW; Zhang LH
    Pharmazie; 2018 Dec; 73(12):692-699. PubMed ID: 30522551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
    Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence.
    Zhou T; Zhang M; Zhao L; Li A; Qin X
    Am J Physiol Cell Physiol; 2016 Oct; 311(4):C572-C582. PubMed ID: 27488664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
    Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
    Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification.
    Lee J; Hong SW; Kim MJ; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    Diabetes Metab J; 2024 Jan; 48(1):83-96. PubMed ID: 38173373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
    Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C
    Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
    Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
    Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells.
    Lee HM; Lee CK; Lee SH; Roh HY; Bae YM; Lee KY; Lim J; Park PJ; Park TK; Lee YL; Won KJ; Kim B
    J Pharmacol Sci; 2007 Sep; 105(1):74-81. PubMed ID: 17895590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.
    Dong X; Yu LG; Sun R; Cheng YN; Cao H; Yang KM; Dong YN; Wu Y; Guo XL
    J Cell Biochem; 2013 Jan; 114(1):174-82. PubMed ID: 22887358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
    Won SM; Park YH; Kim HJ; Park KM; Lee WJ
    Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
    Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE
    J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
    Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
    Hsu JH; Liou SF; Yang SN; Wu BN; Dai ZK; Chen IJ; Yeh JL; Wu JR
    Pediatr Pulmonol; 2014 Aug; 49(8):734-44. PubMed ID: 24167111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways.
    Kyotani Y; Zhao J; Tomita S; Nakayama H; Isosaki M; Uno M; Yoshizumi M
    J Pharmacol Sci; 2010; 113(2):161-8. PubMed ID: 20508392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells.
    Madiraju P; Hossain E; Anand-Srivastava MB
    Mol Cell Biochem; 2018 Nov; 448(1-2):77-89. PubMed ID: 29417337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.